Larsen Elisabeth C, Schmiegelow Kjeld, Rechnitzer Catherine, Loft Anne, Müller Jørn, Andersen Anders Nyboe
The Fertility Clinic, Juliane Marie Center, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
Acta Obstet Gynecol Scand. 2004 Jan;83(1):96-102. doi: 10.1111/j.1600-0412.2004.00332.x.
In contrast to chemotherapy, previous irradiation of the uterus carries an increased risk of an adverse pregnancy outcome. Conflicting results exist as regards the ability of the uterus to increase in volume following radiotherapy-induced damage. We measured uterine volume in a cohort of childhood cancer survivors, and assessed uterine response to a high-dose estrogen replacement regimen.
Uterine volume was assessed by transvaginal sonography in 100 childhood cancer survivors. Three patients with ovarian failure and severely reduced uterine volume following abdominal or pelvic irradiation were treated with percutaneous estradiol 150 microg/24 h for three cycles, and transvaginal uterine sonography was repeated monthly.
Uterine volume was significantly reduced in nulliparous patients who had received direct uterine irradiation (n = 13; median 13 mL, range 1-52 mL) compared with nulliparous patients who had received chemotherapy only (n = 37; 47 mL, 22-88), radiotherapy above the diaphragm (n = 17; 40 mL, 24-61), or radiotherapy below the diaphragm not directly involving the uterus (n = 13; 34 mL, 8-77) (p < 0.02 in all comparisons). Among nulliparous patients a significant correlation was found between age at direct uterine irradiation and uterine volume (r = 0.78, p = 0.002). No significant improvement in uterine volume, endometrial thickness or uterine artery blood flow was observed in three hypogonadal patients in response to high-dose estrogen replacement therapy.
Our results indicate that cytotoxic treatment in childhood does not affect adult uterine size. In contrast, uterine irradiation at a young age reduces adult uterine volume. The radiotherapy-induced damage is probably irreversible.
与化疗不同,既往子宫接受过放疗会增加不良妊娠结局的风险。关于放疗导致损伤后子宫体积增大的能力,存在相互矛盾的结果。我们测量了一组儿童癌症幸存者的子宫体积,并评估了子宫对高剂量雌激素替代方案的反应。
通过经阴道超声对100名儿童癌症幸存者的子宫体积进行评估。对3名因腹部或盆腔放疗导致卵巢功能衰竭且子宫体积严重减小的患者,采用经皮给予150微克/24小时雌二醇治疗三个周期,并每月重复进行经阴道子宫超声检查。
与仅接受化疗的未生育患者(n = 37;中位数47毫升,范围22 - 88毫升)、接受膈上放疗的未生育患者(n = 17;40毫升,24 - 61毫升)或接受膈下放疗但未直接累及子宫的未生育患者(n = 13;34毫升,8 - 77毫升)相比,直接接受子宫放疗的未生育患者(n = 13;中位数13毫升,范围1 - 52毫升)子宫体积显著减小(所有比较中p < 0.02)。在未生育患者中,直接子宫放疗时的年龄与子宫体积之间存在显著相关性(r = 0.78,p = 0.002)。在3名性腺功能减退患者中,高剂量雌激素替代治疗后未观察到子宫体积、子宫内膜厚度或子宫动脉血流有显著改善。
我们的结果表明,儿童期的细胞毒性治疗不影响成年子宫大小。相反,年轻时的子宫放疗会减小成年子宫体积。放疗导致的损伤可能是不可逆的。